Roy Golan - Oct 18, 2023 Form 3/A - Amendment Insider Report for Ayala Pharmaceuticals, Inc. (ADXS)

Role
Chief Financial Officer
Signature
/s/ Roy Golan
Stock symbol
ADXS
Transactions as of
Oct 18, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
11/3/2023, 11:46 AM
Date Of Original Report
Oct 31, 2023

No securities are beneficially owned.